Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)
Close on Nov 18, 2026Market cap $1.98MP/E –Yield –
Can-Fite BioPharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Can-Fite BioPharma's pe ratio was 3.1× on Feb 28, 2018, against 3.6× a year earlier. Over the last 2 years it ranged from 2.4× to 5.3×, with a median of 3.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Feb 28, 2018 | 3.1× | +0.7 |
| 2017 | Dec 29, 2017 | 2.5× | −1.9 |
| 2016 | Dec 30, 2016 | 4.4× | – |
See a number that looks wrong?